Gastroparesis Market Scope And Analysis

  • Report Code : TIPRE00008992
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Gastroparesis Market Analysis and Trends by 2031

Buy Now

Gastroparesis Market Report Gastroparesis Market Size and Share Gastroparesis Market Scope and Analysis

Gastroparesis Market Report Scope

Report Attribute Details
Market size in 2023 US$ 5.03 billion
Market Size by 2031 US$ 7.39 billion
Global CAGR (2023 - 2031) 4.9%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Type
  • Idiopathic
  • Diabetic
  • Post-Surgical
By Drug Class Type
  • Prokinetic Agents
  • Antiemetic Agents
  • Botulinum Toxin Injection
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • EVOKE PHARMA
  • Bausch Health Companies Inc Salix Pharmaceuticals Ltd
  • Johnson And Johnson Services Inc
  • Allergan Plc
  • NEUROGASTRX INC
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Pfizer Inc
  • ANI Pharmaceuticals Inc
  • Ipca Laboratories Ltd
  • Cinrx Pharma LLC Cindome Pharma